C-Ray Therapeutics
Latest round
- Series A
Last raised
- Nov 2024
Total raised
- $106M
Investors
- 6
About C-Ray Therapeutics
Founded in 2021 and based in Chengdu, China, C-Ray Therapeutics operates as a pharmaceutical company that focuses on the development and production of radiopharmaceuticals., Ltd is the branch office of the company. It also has another branch in Beijing. The company has applied for 15 patents. It cooperated with Tongyi Pharmaceutical, Tongrun Bio, and other companies. In June 2023, the company's Zhangjiang R&D laboratory was put into use. C-Ray Therapeutics engages in the research, development, production, clinical application, and commercialization of radiopharmaceuticals. Its related products have been officially approved by the US FDA for clinical treatment. The company provides molecular imaging CRO and companion diagnostic development services, verification services for the drugability of new drugs developed for innovative targets, CRDMO services, etc. The company generates revenue by providing radiopharmaceuticals.
Who invested in C-Ray Therapeutics
6 investors across 3 rounds
See all investors in C-Ray Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about C-Ray Therapeutics
Who invested in C-Ray Therapeutics?
C-Ray Therapeutics has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has C-Ray Therapeutics raised?
C-Ray Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did C-Ray Therapeutics last raise money?
C-Ray Therapeutics's most recent round on record is a Series A, in Nov 2024.
What does C-Ray Therapeutics do?
Founded in 2021 and based in Chengdu, China, C-Ray Therapeutics operates as a pharmaceutical company that focuses on the development and production of radiopharmaceuticals.
Where is C-Ray Therapeutics headquartered?
C-Ray Therapeutics is headquartered in Chengdu, China.
Which VCs invest in companies like C-Ray Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at C-Ray Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like C-Ray Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.